Aerie Pharmaceuticals logo

AERI Aerie Pharmaceuticals

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.

Healthcare Drug Manufacturers—Specialty & Generic CIK: 1337553 

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating